What is the role of acetylcholinesterase inhibitors in Alzheimer's disease?

• A. Inhibit neurotransmitter release
• B. Increase acetylcholine levels
• C. Decrease amyloid plaque formation
• D. Reduce neuroinflammation

Answer: (B)

In Alzheimer's disease, acetylcholinesterase inhibitors are used primarily to increase acetylcholine levels in the brain. Acetylcholine is a neurotransmitter that plays an important role in memory and cognitive function. In individuals with Alzheimer's, there is a significant decrease in acetylcholine due to the degeneration of cholinergic neurons.

By inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine in the synaptic cleft, these drugs prolong the action of acetylcholine, enhancing cholinergic transmission. This action can help to temporarily improve symptoms related to cognition, memory, and overall brain function. While these inhibitors do not directly address the underlying pathophysiology of the disease, such as amyloid plaque formation or neuroinflammation, they offer symptomatic relief and can enhance the quality of life for patients by improving their ability to communicate and carry out daily activities.

This role emphasizes the importance of maintaining higher levels of acetylcholine to potentially counteract some of the cognitive symptoms experienced in Alzheimer's disease.